KSQ Therapeutics, a biotechnology company co-founded by a member of Forbes' 2107 30 Under 30 list, has raised $26 million and appointed a high-profile chief executive.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/10/02/crispr-focused-biotech-co-founded-by-forbes-under-30-alumnus-raises-76-million/
via IFTTT
No comments:
Post a Comment